DUOXA2 and cyclic hematopoiesis: This study investigated the frequency of DUOX2/DUOXA2 mutations in borderline bsTSH GIS CH cases from a single British center, and evaluated the biochemical characteristics and requirement for LT4 treatment in this cohort.